LONDON (Reuters Health) Aug 27 –
All suitable renal dialysis patients should be offered the choice of home haemodialysis, according to guidance set to be approved by Britain’s medicines cost effectiveness watchdog.
In a statement on its Web site Tuesday, the National Institute for Clinical Excellence (NICE) said that annual treatment costs of home haemodialysis were nearly 3000 pounds less than hospital haemodialysis.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!